- Reuters•4 hours ago
Medical device maker St. Jude Medical Inc said on Friday it has paused implanting of one of its cardiac pacemakers due to problems with electronic data reporting. The affected device is the Nanostim leadless cardiac pacemaker (LCP). St. Jude, which is being acquired by Abbott Laboratories, said it had seven reports of lost telemetry and heart pacing output from the devices.
- Moody's•7 hours ago
Approximately $1.91 Billion of Structured Securities Affected. New York, October 28, 2016-- Moody's Investors Service has upgraded the ratings on four classes, downgraded the rating on one class and affirmed ...
- PR Newswire•yesterday
"Abbott is unique in that we've been adding to our reservoir of scientific knowledge for 128 years," said John Frels, Ph.D., chair of Abbott's Scientific Governing Board, which oversees the company's senior scientific career track. "We strive to bring in the best and brightest scientists and engineers to work on some of the biggest problems in healthcare today.
Abbott Laboratories (ABT)
NYSE - NYSE Delayed Price. Currency in USD
|Bid||39.53 x 70200|
|Ask||39.54 x 4500|
|Day's Range||39.51 - 40.60|
|52wk Range||36.00 - 46.38|
|1y Target Est||N/A|
Trade prices are not sourced from all markets
|P/E Ratio (ttm)||43.26|
|Avg Vol (3m)||9,039,020|
|Dividend & Yield||1.04 (2.60%)|